Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression
収録刊行物
-
- Endocrine Related Cancer
-
Endocrine Related Cancer 21 (5), 755-767, 2014-07-10
Bioscientifica